137 related articles for article (PubMed ID: 25630385)
1. Linezolid is a novel and effective treatment for septic pulmonary embolism.
Yasuda M; Inokuchi R; Ohshima K; Yamamoto M; Tokunaga K; Fukuda T; Nakamura K
Am J Emerg Med; 2015 Jul; 33(7):988.e3-4. PubMed ID: 25630385
[TBL] [Abstract][Full Text] [Related]
2. Ineffectiveness of daptomycin in the treatment of septic pulmonary emboli and persistent bacteremia caused by methicillin-resistant Staphylococcus aureus.
Hagiya H; Hagioka S; Otsuka F
Intern Med; 2013; 52(22):2577-82. PubMed ID: 24240800
[TBL] [Abstract][Full Text] [Related]
3. Persistent methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia due to a linezolid "tolerant" strain.
Cunha BA; Nausheen S; Schoch P
Heart Lung; 2010; 39(2):173-5. PubMed ID: 20207279
[TBL] [Abstract][Full Text] [Related]
4. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.
Jang HC; Kim SH; Kim KH; Kim CJ; Lee S; Song KH; Jeon JH; Park WB; Kim HB; Park SW; Kim NJ; Kim EC; Oh MD; Choe KW
Clin Infect Dis; 2009 Aug; 49(3):395-401. PubMed ID: 19569970
[TBL] [Abstract][Full Text] [Related]
5. Persistent methicillin-resistant Staphylococcus aureus (MRSA) bacteremia due to a linezolid "tolerant" strain.
Cunha BA; Mikail N; Eisenstein L
Heart Lung; 2008; 37(5):398-400. PubMed ID: 18790342
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Park HJ; Kim SH; Kim MJ; Lee YM; Park SY; Moon SM; Park KH; Chong YP; Lee SO; Choi SH; Woo JH; Kim YS
J Infect; 2012 Dec; 65(6):505-12. PubMed ID: 22902942
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis and with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias.
Melzer M; Goldsmith D; Gransden W
Clin Infect Dis; 2000 Jul; 31(1):208-9. PubMed ID: 10913433
[No Abstract] [Full Text] [Related]
8. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
9. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
Pangercić A; Bukovski-Simonoski S; Barsić B
Lijec Vjesn; 2010; 132 Suppl 1():11-3. PubMed ID: 20715711
[TBL] [Abstract][Full Text] [Related]
10. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-resistant Staphylococcus aureus-related septic pulmonary embolism and sacroiliitis treated with long-term linezolid in a patient with adult-onset Still's disease.
Horai Y; Izumikawa K; Oka S; Nakashima Y; Suzuki T; Nakajima H; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Kohno S; Kawakami A
Intern Med; 2014; 53(9):1023-7. PubMed ID: 24785897
[TBL] [Abstract][Full Text] [Related]
12. Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies.
Shorr AF; Kunkel MJ; Kollef M
J Antimicrob Chemother; 2005 Nov; 56(5):923-9. PubMed ID: 16195255
[TBL] [Abstract][Full Text] [Related]
13. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
14. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
Stevens DL; Herr D; Lampiris H; Hunt JL; Batts DH; Hafkin B
Clin Infect Dis; 2002 Jun; 34(11):1481-90. PubMed ID: 12015695
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of long-term treatment with linezolid in cystic fibrosis: case report.
Spicuzza L; Sciuto C; La Rosa M
J Chemother; 2008 Jun; 20(3):399-401. PubMed ID: 18606604
[No Abstract] [Full Text] [Related]
16. Endocarditis caused by methicillin-resistant Staphylococcus aureus: treatment failure with linezolid.
Ruiz ME; Guerrero IC; Tuazon CU
Clin Infect Dis; 2002 Oct; 35(8):1018-20. PubMed ID: 12355391
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Dailey CF; Dileto-Fang CL; Buchanan LV; Oramas-Shirey MP; Batts DH; Ford CW; Gibson JK
Antimicrob Agents Chemother; 2001 Aug; 45(8):2304-8. PubMed ID: 11451689
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
19. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
Itani KM; Weigelt J; Li JZ; Duttagupta S
Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intravenous linezolid in an allogeneic cord blood stem cell transplant recipient.
Higa T; Tasaka T; Kubo Y; Nakagiri I; Sano F; Matsuhashi Y; Fukai Y; Wada H; Tohyama K; Sugihara T
Scand J Infect Dis; 2008; 40(11-12):990-2. PubMed ID: 18651266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]